| Dr Justin Lee Anderson, PHARMD | |
|
153 Cesar Chavez St, Saint Paul, MN 55107-2226 | |
| (651) 602-7589 | |
| Not Available |
| Full Name | Dr Justin Lee Anderson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 153 Cesar Chavez St, Saint Paul, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013350644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 120832 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Lee Anderson, PHARMD 153 Cesar Chavez St, Saint Paul, MN 55107-2226 Ph: (651) 602-7589 | Dr Justin Lee Anderson, PHARMD 153 Cesar Chavez St, Saint Paul, MN 55107-2226 Ph: (651) 602-7589 |
News Archive
Drinking just one energy drink may have a detrimental effect on blood vessel function, according to a study to be presented at the American Heart Association's Scientific Sessions 2018 in Chicago.
Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.
In her latest Kaiser Health News consumer column, Michelle Andrews writes: "Preventive health care is important at any age, but never more so than as we get older.
"The $100 billion medical-device industry is scrambling to reverse billions of dollars in fees proposed by the Senate Finance Committee, but it faces trouble because its reluctance to offer concessions alienated some lawmakers," the Wall Street Journal reports.
CVRx, Inc. reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos System to treat heart failure. The Rheos System uses Baroreflex Activation Therapy® technology, an entirely new non-pharmaceutical approach designed to treat cardiovascular disease. The HOPE4HF Trial is being conducted under an approved investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).
› Verified 5 days ago
Beth J Alexander, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1302 Palace Ave, Saint Paul, MN 55105 Phone: 651-699-0290 Fax: 612-330-1757 | |
Avni A Novotny, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2199 Highway 36 E, Saint Paul, MN 55109 Phone: 651-779-6341 Fax: 651-234-4734 | |
Mrs. Juli A Park Jankowski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1788 Old Hudson Rd, Saint Paul, MN 55119 Phone: 651-731-9633 Fax: 651-731-9678 | |
Dr. Eddie Kit Huie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 734 Grand Ave, Saint Paul, MN 55105 Phone: 651-227-5422 | |
Fan Zhang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 345 Smith Ave N, Saint Paul, MN 55102 Phone: 651-220-6820 | |
Jeff Ray Digre, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1440 University Ave W, Saint Paul, MN 55104 Phone: 651-646-8858 Fax: 651-646-9699 |